Non-Hormonal Menopause Treatment Options: What to Do When Hormones Aren’t Right for You

June 24, 2026:

Non-Hormonal Menopause Treatment Options: What to Do When Hormones Aren’t Right for You

Hot flashes, vaginal dryness, sleep disruption, and mood changes are some of the most common symptoms women experience during menopause and perimenopause. While hormone therapy can be highly effective, it’s not the right choice for everyone.

The good news? There are several non-hormonal menopause treatment options available that can help manage symptoms and improve quality of life.

Whether you prefer to avoid hormones or have medical reasons that make hormone therapy less appropriate, you still have options.

Why Some Women Choose Non-Hormonal Menopause Treatments

Women seek non-hormonal menopause relief for many different reasons.

Some may not be candidates for hormone therapy, while others simply prefer a non-hormonal approach. Fortunately, there are FDA-approved medications, vaginal therapies, lifestyle modifications, and other treatments that can help address common menopause symptoms.

The key is finding the approach that works best for your symptoms and your goals.

Non-Hormonal Medications for Menopause Symptoms

Several FDA-approved non-hormonal treatments are available for specific menopause symptoms.

Osphena® (Ospemifene)

Osphena is a prescription medication approved to treat vaginal dryness and painful intercourse associated with menopause.

For women experiencing discomfort during intimacy due to vaginal tissue changes, Osphena may provide relief without using estrogen therapy.

Brisdelle® (Paroxetine)

Brisdelle is a non-hormonal medication approved to help reduce hot flashes.

For women struggling with bothersome vasomotor symptoms, such as sudden heat sensations and night sweats, Brisdelle can be an effective treatment option.

MonaLisa Touch®: A Hormone-Free Treatment for Vaginal Symptoms

One of the most popular non-hormonal treatment options offered at Maze Women’s Health is MonaLisa Touch®.

This quick, in-office laser treatment is designed to improve vaginal health without the use of hormones. Many women choose MonaLisa Touch to address symptoms such as:

Vaginal dryness
Discomfort during intercourse
Vaginal irritation
Genitourinary symptoms of menopause

The treatment is fast, requires no hormones, and has become an appealing option for women seeking non-hormonal symptom relief.

Over the Counter Solutions for Vaginal Dryness

Not every woman requires prescription treatment.

Many women find relief using:

Vaginal moisturizers
Personal lubricants
Regular vaginal hydration products

Because every woman responds differently, it may take some trial and error to find the product that feels most comfortable.

Lifestyle Changes That Can Help

For women with mild to moderate symptoms, simple lifestyle modifications can make a meaningful difference.

Helpful strategies may include:

Dressing in light layers to prevent overheating
Exercising regularly to reduce stress
Limiting caffeine
Reducing alcohol consumption
Avoiding spicy foods that may trigger hot flashes
Prioritizing healthy sleep habits

While lifestyle changes may not eliminate symptoms completely, they can often reduce their frequency and severity.

The Bottom Line

Menopause treatment is not one-size-fits-all.

If hormone therapy isn’t right for you, there are still many effective ways to manage symptoms. From FDA-approved medications and MonaLisa Touch® to lifestyle changes and non-prescription options, women today have more choices than ever before.

At Maze Women’s Health, we work with each patient to create an individualized treatment plan based on her symptoms, medical history, and personal preferences, helping women find relief and feel their best throughout menopause and beyond.

Source link

tags

Abkhazia Afghanistan Africa Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Comoros Costa Rica Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Fiji Finland France French Polynesia Gabon Gambia Georgia Germany Ghana Greece Grenada Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea North Macedonia Northern Cyprus Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Republic of the Congo Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Korea South Sudan Spain Sri Lanka Sudan Suriname Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Transnistria Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda UK Ukraine United Arab Emirates Uruguay USA Uzbekistan Vanuatu Vatican City Venezuela Vietnam Western Sahara Yemen Zambia Zimbabwe